“…Such studies have significantly contributed to our understanding of the underlying barriers hindering the homogeneous distribution of nanomedicines within tumors. In turn, strategic exploitation of tumor-specific properties has been achieved through physical and pharmacological modulators, enabling enhanced delivery of drug, and/or superior anti-tumor efficacy [7,[18][19][20][21].…”